# | Aladdin ID | Assay Type | Description | Organism | Compounds | Reference | BAO Format | Source | |
---|---|---|---|---|---|---|---|---|---|
1. | ALA751751 | B | Ability to inhibit the deacetylation of [acetyl-3H]-N8-Acetylspermidine deacetylase in rat liver. | Rattus norvegicus | 16 | ALA1124471 | assay format | Scientific Literature | |
2. | ALA2185555 | A | Metabolic stability of the compound assessed as human recombinant APAO-mediated compound degradation at 0.5 to 1 mM after 5 to 60 mins in presence of benzaldehyde | Homo sapiens | 6 | ALA2177009 | single protein format | Scientific Literature | |
3. | ALA2185556 | A | Metabolic stability in N1,N11-diethyl-norspermine pretreated human DU145 cells expressing SSAT assessed as accumulation of acetylated derivatives of compound in medium at 100 uM after 48 hrs | Homo sapiens | 6 | ALA2177009 | cell-based format | Scientific Literature | |
4. | ALA3541433 | A | Drug level in human HepG2 cells assessed as SSAT2-mediated compound formation treated with TETA at 1 mM for 24 hrs | Homo sapiens | 3 | ALA3526099 | cell-based format | Scientific Literature | |
5. | ALA3541434 | A | Drug level in human HepG2 cells assessed as SSAT1-mediated compound formation treated with SpmTrien at 100 uM for 24 hrs | Homo sapiens | 3 | ALA3526099 | cell-based format | Scientific Literature |